Functional abnormalities in the primary orofacial sensorimotor cortex during speech in Parkinson's disease

Movement Disorders

Volumn 22, Issue 14, 2007, Pages 2043-2051

  Rektorova, Irena ^a   Barrett, Jennifer ^b   Mikl, Michal ^a   Rektor, Ivan ^a   Paus, Tomas ^b,c  

^a ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Functional magnetic resonance imaging; Overt reading; Paralinguistic aspects of speech; Parkinson's disease

Indexed keywords

LEVODOPA;

ADULT; AGED; ARTICLE; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN BLOOD LEVEL; PARKINSON DISEASE; PRIORITY JOURNAL; SENSORIMOTOR CORTEX; SPEECH;

ACOUSTIC STIMULATION; AGED; BRAIN MAPPING; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; OXYGEN; PARKINSON DISEASE; SOMATOSENSORY CORTEX; SPEECH; SPEECH ACOUSTICS; STATISTICS AS TOPIC;

EID: 37549067339     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.21548     Document Type: Article

References (37)

1. Sakurai Y, Momose T, Iwata M, Sudo Y, Ohtomo K, Kanazawa I. Cortical activity associated with vocalization and reading proper. Cogn Brain Res 2001;12:161-165.
2. McNeilage PF, Davis BL. Motor mechanisms in speech ontogeny: phylogenetic, neurobiological and linguistic implications. Curr Opin Neurobiol 2001;11:697-700.
3. Dronkers NF. A new brain region for coordinating speech articulation. Nature 1996;384:159-161.
4. Wise RJ, Greene J, Buchel C, Scott SK. Brain regions involved in articulation. Lancet 1999;353:1057-1061.
5. Pinto S, Ozsancak C, Tripoliti E, Thobois S, Limousin-Dowsey P, Auzou P. Treatments for dysarthria in Parkinson's disease. Lancet Neurol 2004;3:547-556.
6. Jimenez-Jimenez FJ, Gamboa J, Nieto A, et al. Acoustic voice analysis in untreated patients with Parkinson's disease. Parkinsonism Relat Disord 1997;3:111-116.
7. Pinto S, Gentil M, Fraix V, Benabid AL, Pollak P. Bilateral subthalamic stimulation effects on oral force control in Parkinson's disease. J Neurol 2003;250:179-187.
8. Gentil M, Chauvin P, Pinto S, Pollak P, Benabid AL. Effect of bilateral stimulation of the subthalamic nucleus on parkinsonian voice. Brain Lang 2001;78:233-240.
9. Wolfe VI, Garvin JS, Bacon M, Waldrop W. Speech changes in Parkinson's disease during treatment with L-dopa. J Commun Disord 1975;8:271-279.
10. Critchley EM. Speech disorders of Parkinsonism: a review. J Neurol Neurosurg Psychiatry 1981;44:751-758.
11. Dromney Ch, Kumar R, Lang AE, Lozano AM. An investigation of the effects of subthalamic nucleus stimulation on acoustic measures of voice. Mov Disord 2000;15:1132-1138.
12. Deuschl G, Herzog J, Kleiner-Fisman G, et al. Deep brain stimulation: Postoperative issues. Mov Disord 2006;21 (Suppl 14): S219-S237.
13. Pinto S, Thobois S, Costes N, et al. Subthalamic nucleus stimulation and dysarthria in Parkinson's disease: a PET study. Brain 2004;127:602-615.
14. Liotti M, Ramig LO, Vogel D, et al. Hypophonia in Parkinson's disease: neural correlates of voice treatment revealed by PET. Neurology 2003;60:432-440.
15. Gibb WRG, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988;51:745-752.
16. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
17. Fahn S, Elston RL, Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Goldstein M, Calne DB, editors. Recent developments in Parkinson's disease, vol. 2. New York: MacMillan; 1987; p 153-163.
18. Barrett J, Pike GB, Paus T. The role of the anterior cingulate cortex in pitch variation during sad affect. Eur J Neurosci 2004;19:458-464.
19. Barrett J, Paus T. Affect-induced changes in speech production. Exp Brain Res 2002;146:531-537.
20. Ludlow CL. Stuttering: dysfunction in a complex and dynamic system. Brain 2000;123:1983-1984.
21. Murphy K, Corfield DR, Guz A, et al. Cerebral areas associated with motor control of speech in humans. J Appl Physiol 1997;83:1438-1447.
22. Milham MP, Erickson KI, Banich MT, et al. Attentional control in the aging brain: insights from an fMRI study of the Stroop task. Brain Cogn 2002;49:277-296.
23. Dronkers NF. A new brain region for coordinating speech articulation. Nature 1996;384:159-161.
24. McClean MD, Dostrovsky JO, Lee L, Tasker RR. Somatosensoryneurons in human thalamus respond to speech-induced orofacial movements. Brain Res 1990;513:343-347.
25. Riecker A, Mathiak K, Wildgruber D, et al. fMRI reveals two distinct cerebral networks subserving speech motor control. Neurology 2005;64:700-706.
26. Gitelman DR, Nobre AC, Sonty S, Parrish TB, Mesulam M. Language network specializations: an analysis with parallel task designs and functional magnetic resonance imaging. Neuroimage 2005;26:975-985.
27. Ravizza SM. Relating selective brain damage to impairments with voicing contrasts. Brain Lang 2001;77:95-118.
28. Dias AE, Barbosa ER, Coracini K, Maia F, Marcolin MA, Fregni F. Effects of repetitive transcranial magnetic stimulation on voice and speech in Parkinson's disease. Acta Neurol Scand 2006;113:92-99.
29. Alexander GE, Crutcher MD. Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci 1990;13:266-271.
30. Wichmann T, DeLong MR. Functional and pathophysiological models of the basal ganglia. Curr Opin Neurobiol 1996;6:751-758.
31. Lefaucheur JP. Motor cortex dysfunction revealed by cortical excitability studies in Parkinson's disease: influence of antiparkinsonian treatment and cortical stimulation. Clin Neurophysiol 2005;116:244-253.
32. Haslinger B, Erhard P, Kampfe N, et al. Event-related functional magnetic resonance imaging in Parkinson's disease before and after levodopa. Brain 2001;124:558-570.
33. Sabatini U, Boulanouar K, Fabre N, et al. Cortical motor reorganization in akinetic patients with Parkinson's disease: a functional MRI study. Brain 2000;123:394-403.
34. Ridding MC, Inzelberg R, Rothwell JC. Changes in excitability of motor cortical circuitry in patients with Parkinson's disease. Ann Neurol 1995;37:181-188.
35. Cantello R. Applications of transcranial magnetic stimulation in movement disorders. J Clin Neurophysiol 2002;19:272-293.
36. Payoux P, Remy P, Damier P, et al. Subthalamic nucleus stimulation reduces abnormal motor cortical overactivity in Parkinson disease. Arch Neurol 2004;61:1307-1313.
37. Haslinger B, Kalteis K, Boecker H, Alesch F, Ceballos-Baumann AO. Frequency-correlated decreases of motor cortex activity associated with subthalamic nucus stimulation in Parkinson's disease. Neuroimage 2005;28:598-606.